Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64.
Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–32.
Wiltink LM, White K, King MT, Rutherford C. Systematic review of clinical practice guidelines for colorectal and anal cancer: the extent of recommendations for managing long-term symptoms and functional impairments. Support Care Cancer. 2020;28(6):2523–32.
Article PubMed PubMed Central Google Scholar
Zhou L, Wang JZ, Wang JT, Wu YJ, Chen H, Wang WB, Cao F, Cheng GX. Correlation analysis of MR/CT on colorectal cancer lymph node metastasis characteristics and prognosis. Eur Rev Med Pharmacol Sci. 2017;21(6):1219–25.
Hadjipetrou A, Anyfantakis D, Galanakis CG, Kastanakis M, Kastanakis S. Colorectal cancer, screening and primary care: a mini literature review. World J Gastroenterol. 2017;23(33):6049–58.
Article PubMed PubMed Central Google Scholar
Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–85.
Article CAS PubMed Google Scholar
Balyasnikova S, Brown G. Imaging advances in colorectal cancer. Curr Colorectal Cancer Rep. 2016;12:162–9.
Article PubMed PubMed Central Google Scholar
Kijima S, Sasaki T, Nagata K, Utano K, Lefor AT, Sugimoto H. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J Gastroenterol. 2014;20(45):16964–75.
Article PubMed PubMed Central Google Scholar
Kumamoto T, Shindoh J, Mita H, Fujii Y, Mihara Y, Takahashi M, Takemura N, Shirakawa T, Shinohara H, Kuroyanagi H. Optimal diagnostic method using multidetector-row computed tomography for predicting lymph node metastasis in colorectal cancer. World J Surg Oncol. 2019;17(1):39.
Article PubMed PubMed Central Google Scholar
Goiffon RJ, O’Shea A, Harisinghani MG. Advances in radiological staging of colorectal cancer. Clin Radiol. 2021;76(12):879–88.
Article CAS PubMed Google Scholar
Scheenen TWJ, Zamecnik P. The role of magnetic resonance imaging in (future) cancer staging: note the nodes. Invest Radiol. 2021;56(1):42–9.
Lee DH, Lee JM. Whole-body PET/MRI for colorectal cancer staging: Is it the way forward? J Magn Reson Imaging. 2017;45(1):21–35.
Kang B, Lee JM, Song YS, Woo S, Hur BY, Jeon JH, Paeng JC. Added value of integrated whole-body PET/MRI for evaluation of colorectal cancer: comparison with contrast-enhanced MDCT. AJR Am J Roentgenol. 2016;206(1):W10-20.
Yoon JH, Lee JM, Chang W, Kang HJ, Bandos A, Lim HJ, Kang SY, Kang KW, Ryoo SB, Jeong SY, et al. Initial M staging of rectal cancer: FDG PET/MRI with a hepatocyte-specific contrast agent versus contrast-enhanced CT. Radiology. 2020;294(2):310–9.
Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, et al. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technol Assess (Winchester, England). 2011;15(35):1–192.
Kang SK, Zhang A, Pandharipande PV, Chandarana H, Braithwaite RS, Littenberg B. DWI for renal mass characterization: systematic review and meta-analysis of diagnostic test performance. AJR Am J Roentgenol. 2015;205(2):317–24.
Bae SU, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Which patients with isolated para-aortic lymph node metastasis will truly benefit from extended lymph node dissection for colon cancer? Cancer Res Treat. 2018;50(3):712–9.
Article CAS PubMed Google Scholar
Dinnes J, Deeks J, Kirby J, Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess (Winchester, England). 2005;9(12):1–113.
Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
Article PubMed PubMed Central Google Scholar
Sheikhbahaei S, Taghipour M, Ahmad R, Fakhry C, Kiess AP, Chung CH, Subramaniam RM. Diagnostic accuracy of follow-up FDG PET or PET/CT in patients with head and neck cancer after definitive treatment: a systematic review and meta-analysis. AJR Am J Roentgenol. 2015;205(3):629–39.
Komori K, Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Shiomi A, Ohue M, Ota M, Akazai Y, Shiozawa M, et al. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): the analysis of data from the clinical trial (JCOG0212). Eur J Surg Oncol. 2019;45(3):336–40.
Seto S, Tsujikawa T, Sawai K, Kurebayashi H, Morikawa M, Okazawa H, Goi T. Feasibility of [18F]FDG PET/MRI with early-delayed and extended PET as one-stop imaging for staging and predicting metastasis in rectal cancer. Oncology. 2022;100(4):212–20.
Article CAS PubMed Google Scholar
Catalano OA, Lee SI, Parente C, Cauley C, Furtado FS, Striar R, Soricelli A, Salvatore M, Li Y, Umutlu L, et al. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. Eur J Nucl Med Mol Imaging. 2021;48(4):1235–45.
Crimi F, Spolverato G, Lacognata C, Garieri M, Cecchin D, Urso ED, Zucchetta P, Pucciarelli S, Pomerri F. 18F-FDG PET/MRI for rectal cancer TNM restaging after preoperative chemoradiotherapy: initial experience. Dis Colon Rectum. 2020;63(3):310–8.
Brendle C, Schwenzer NF, Rempp H, Schmidt H, Pfannenberg C, la Fougere C, Nikolaou K, Schraml C. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. Eur J Nucl Med Mol Imaging. 2016;43(1):123–32.
Article CAS PubMed Google Scholar
Lee SJ, Seo HJ, Kang KW, Jeong SY, Yi NJ, Lee JM, Chung JK, Edmund Kim E, Paeng JC, Cheon GJ, et al. Clinical performance of whole-body 18F-FDG PET/Dixon-VIBE, T1-weighted, and T2-weighted MRI protocol in colorectal cancer. Clin Nucl Med. 2015;40(8):e392-398.
Li Y, Mueller LI, Neuhaus JP, Bertram S, Schaarschmidt BM, Demircioglu A, Ludwig JM, Kirchner J, Rischpler C, Herrmann K, et al. (18)F-FDG PET/MR versus MR alone in whole-body primary staging and restaging of patients with rectal cancer: what is the benefit of PET? J Clin Med. 2020. https://doi.org/10.3390/jcm9103163.
Article PubMed PubMed Central Google Scholar
Maffione AM, Rubello D, Caroli P, Colletti PM, Matteucci F. Is It Time to introduce PET/CT in colon cancer guidelines? Clin Nucl Med. 2020;45(7):525–30.
Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, Brown G, McLeod R, Kennedy E. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19(7):2212–23.
Fraum TJ, Fowler KJ, McConathy J. PET/MRI: emerging clinical applications in oncology. Acad Radiol. 2016;23(2):220–36.
Kim SH, Song BI, Kim BW, Kim HW, Won KS, Bae SU, Jeong WK, Baek SK. Predictive value of [(18)F]FDG PET/CT for Lymph Node metastasis in rectal cancer. Sci Rep. 2019;9(1):4979.
Article PubMed PubMed Central Google Scholar
Lu YY, Chen JH, Ding HJ, Chien CR, Lin WY, Kao CH. A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT. Nucl Med Commun. 2012;33(11):1127–33.
Crimi F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, Albertoni L, Spimpolo A, Evangelista L, Zucchetta P, et al. [18F]FDG PET/MRI in rectal cancer. Ann Nucl Med. 2021;35(3):281–90.
Article PubMed PubMed Central Google Scholar
Paspulati RM, Partovi S, Herrmann KA, Krishnamurthi S, Delaney CP, Nguyen NC. Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study. Abdom Imaging. 2015;40(6):1415–25.
留言 (0)